SITC Archive Library

2018 Immuno-Oncology Biomarkers: State of the Art - Session II: Validation of Biomarkers Identification and Analysis 

05-23-2018 13:48

The Society for Immunotherapy of Cancer (SITC) hosted the 2018 Immuno-Oncology Biomarkers: State of the Art on May 16-17, 2018. Available here are the presentation slides and video from Session II: Validation of Biomarkers Identification and Analysis.


Program Committee

  • Chair: Lisa H. Butterfield, PhD – University of Pittsburgh
  • Mary L. Disis, MD, FACP – University of Washington
  • Bernard A. Fox, PhD – Earle A. Chiles Research Institute, Robert W. Franz Cancer Center
  • David Kaufman, MD, PhD – Bill & Melinda Gates Medical Center
  • Samir N. Khlief, MD – Georgetown University
  • Ena Wang, MD – AbbVie Biotherapeutics Corp.


Session Co-Chairs

  • Bernard A. Fox, PhD – Earle A. Chiles Research Institute, Robert W. Franz Cancer Center
  • Sacha Gnjatic, PhD – Icahn School of Medicine at Mount Sinai


Program Summary

The Immuno-Oncology Biomarkers Workshop will identify the next steps for action in immunotherapy biomarker development. It will provide a forum for energetic discussion about the collaborative efforts across several societies and consortia, make progress on identification and analysis of novel biomarkers, and tackle data analysis and specimen sharing. The final session will bring together representatives from the fields of immune-oncology research, infectious disease, autoimmune disease and cell biology to discuss opportunities for cross-disciplinary collaboration to advance biomarker development.

Panel discussions following each didactic presentation will allow all participants to contribute to the conversation, and to shape the innovative collaborations, next projects and other outputs that the SITC Immune Biomarkers Committee will incorporate over the next several years.

Intended Audience

The target audience for this program includes a broad representation from academia, biotech, pharma, government, researchers and early career individuals who wish to understand the biomarkers state of the art, discuss current hurdles to further success, and consider recommendations to move the field forward.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#Biomarkers#ColonCancer#ColorectalCancer#LungCancers#Melanoma
#PresentationSlides#Video#BiomarkersWorkshops#SITC#Cytokines
#Clinician#Oncologist#Researcher#2018

Statistics
0 Favorited
182 Views
6 Files
0 Shares
333 Downloads
Attachment(s)
pdf file
"Session Introduction and Immunoscore Task Force" - Prese...   4.26 MB   1 version
Uploaded - 05-23-2018
Meeting: 2018 Immuno-Oncology Biomarkers: State of the Art; Presenter: Bernard A. Fox, PhD – Earle A. Chiles Research Institute, Robert W. Franz Cancer Center; Date: May 16, 2018
mp4 file
"Session Introduction and Immunoscore Task Force" - Video   206.48 MB   1 version
Uploaded - 07-03-2018
Meeting: 2018 Immuno-Oncology Biomarkers: State of the Art; Presenter: Bernard A. Fox, PhD – Earle A. Chiles Research Institute, Robert W. Franz Cancer Center; Date: May 16, 2018
pdf file
Seeing is Believing - Dissecting Local Immune-Tumor Inte...   50.93 MB   1 version
Uploaded - 05-23-2018
Meeting: 2018 Immuno-Oncology Biomarkers: State of the Art; Presenter: Evan Newell, PhD – Singapore Immunology Network; Date: May 16, 2018
mp4 file
Seeing is Believing - Dissecting Local Immune-Tumor Inte...   324.16 MB   1 version
Uploaded - 07-03-2018
Meeting: 2018 Immuno-Oncology Biomarkers: State of the Art; Presenter: Evan Newell, PhD – Singapore Immunology Network; Date: May 16, 2018
pdf file
Predicting Tumor Evolution from Immune Interactions" - P...   1.58 MB   1 version
Uploaded - 05-23-2018
Meeting: 2018 Immuno-Oncology Biomarkers: State of the Art; Presenter: Marta Luksza, PhD – Institute for Advanced Study; Date: May 16, 2018
mp4 file
Predicting Tumor Evolution from Immune Interactions" - V...   289.33 MB   1 version
Uploaded - 06-01-2018
Meeting: 2018 Immuno-Oncology Biomarkers: State of the Art; Presenter: Marta Luksza, PhD – Institute for Advanced Study; Date: May 16, 2018